Wuhan YZY Biopharma Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-84.73	-97.6	-191.7	-188.87	-148.52
Depreciation & Amortization	4.44	6.57	7.32	6.94	7.62
Loss (Gain) From Sale of Assets	0.02	0.07	0.02	0	0.55
Loss (Gain) From Sale of Investments	-	-	-1.61	-0.67	-1.26
Stock-Based Compensation	1.17	0.48	-	1.58	39.65
Other Operating Activities	4.15	-0.45	3.26	2.19	14.81
Change in Inventory	0.98	1.51	4.85	-1.71	-0.52
Change in Accounts Payable	-4.45	7.03	12.52	9.47	0.45
Change in Unearned Revenue	-5.36	20.44	-2.34	1.8	0.25
Change in Other Net Operating Assets	62.22	-38.77	-18.34	-7.44	-11.73
Operating Cash Flow	-21.58	-100.72	-186.02	-176.7	-98.71
Capital Expenditures	-0.89	-1.51	-1.93	-1.41	-1.9
Sale of Property, Plant & Equipment	-	-	-	-	0.05
Investment in Securities	-	-	48.61	-26.83	-18.24
Other Investing Activities	0.76	-3.16	8.13	34.04	0.16
Investing Cash Flow	-0.13	-4.67	54.81	5.8	-19.93
Short-Term Debt Issued	-	-	-	76.5	28
Long-Term Debt Issued	79.9	129.4	89.5	-	-
Total Debt Issued	79.9	129.4	89.5	76.5	28
Short-Term Debt Repaid	-	-	-	-28	-92.07
Long-Term Debt Repaid	-79.63	-92.3	-77.28	-0.44	-0.41
Total Debt Repaid	-79.63	-92.3	-77.28	-28.44	-92.48
Net Debt Issued (Repaid)	0.27	37.1	12.22	48.06	-64.48
Issuance of Common Stock	-	-	173.96	200	149.91
Other Financing Activities	-4.95	-4.08	-9.88	-6.73	-4.4
Financing Cash Flow	-4.68	33.02	176.29	241.33	81.03
Foreign Exchange Rate Adjustments	0.18	1.95	-1.92	-	-
Net Cash Flow	-26.21	-70.41	43.16	70.44	-37.61
Free Cash Flow	-22.46	-102.22	-187.95	-178.11	-100.61
Free Cash Flow Margin	-33.60%	-94.81%	-	-7822.31%	-827.14%
Free Cash Flow Per Share	-0.12	-0.53	-1.01	-1.03	-0.66
Cash Interest Paid	4.95	4.08	2.39	2.47	4
Levered Free Cash Flow	4.82	-73.78	-68.9	-92.77	-
Unlevered Free Cash Flow	7.92	-71.24	-67.4	-91.22	-
Change in Working Capital	53.39	-9.79	-3.31	2.12	-11.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.